Wake Forest Institute for Regenerative Medicine Young Investigator Award
The Wake Forest Institute for Regenerative Medicine is committed to the development and dissemination of novel therapies for the repair and replacement of diseased tissues and organs. One way to achieve this goal is to foster the careers of young investigators to encourage them to find solutions to problems in regenerative medicine. As part of this effort, the Wake Forest Institute for Regenerative Medicine Young Investigator Award was first awarded at the TERMIS-NA Conference and Exposition in 2008. The award is designed to recognize outstanding achievements by members of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) who are in the early stages of a career in regenerative medicine.
The Wake Forest Institute for Regenerative Medicine Young Investigator Award will be presented at the TERMIS AM between December 3-6, 2017 to two (2) individuals in the early stages of their research careers (graduate student or post-doctoral fellow). Each awardee will be invited to present their conference abstract during the TERMIS-AM meeting, will be presented with a certificate of award, and will receive a monetary award of $2,500 (U.S.).
Recipients of the 2017 WFIRM Young Investigator Awards are:
Dr. Elham Ghadiri is a postdoctoral researcher in the group of Prof. Warren S. Warren at Duke University. Dr. Ghadiri completed her Ph.D. in Nanoscience and Nanotechnology at the Sharif University of Technology. She obtained a second Ph.D. degree in Chemistry from Swiss Federal Polytechnique University in Lausanne (EPFL) under the research guidance of Prof. Jacques Moser and Prof. Michael Gratzel (the millennium prize laureate and one of the top-ten most cited Chemists). The heart of her research is developing and integrating state-of-the-art ultrafast time-resolved microscopy/spectroscopy techniques as well as nanomaterial-based device fabrications for the two important fields of optoelectronics and biomedical science. During her research at EPFL, she developed the first time ever-ultrafast pump-probe diffuse reflectance spectrometer with a unique sub-200 femtosecond time resolution. At Duke, she integrated the novel ultrafast time-resolved nonlinear microscopy techniques for non-invasive label-free early diagnosis of melanoma cancer. She has authored several highly cited publications in journals such as Nat. Commun., Sci. Rep., Nano Lett., that were also highlighted in the science and engineering news, C&EN of American Chemical Society (ACS) and Materials Research Society (MRS) Bulletin.
Tania Baltazar is a 4th year PhD student in Bioengineering - Cell Therapies and Regenerative Medicine at Instituto Superior Técnico (IST, Lisbon, Portugal), under the joint supervision of Dr. Frederico Ferreira at IST and Dr. Pankaj Karande at the Rensselaer Polytechnic Institute (RPI, NY). She completed her BS in Biology from the University of Lisbon in 2011 and received her MS in Biotechnology from IST in 2013. Her current research project is aimed at the development of the first 3D bioprinted in vitro model of vascularized human skin for efficacy screening and regenerative medicine applications. This will serve as the basis for developing an “off-the-shelf” product not only important for the success of permanent engraftment, but also crucial in the evaluation of systemic exposure of topical agents and disease modeling of inflammatory conditions. Since 2015, Tania has been developing these models at RPI under the supervision of Dr. Pankaj Karande, whose research group has led the early work in 3D bioprinting of human skin.